Trials / Completed
CompletedNCT04719013
Treatment With the Evoke System for Facial and Submental Laxity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- InMode MD Ltd. · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area
Detailed description
The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area Prospective, open label clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Evoke radiofrequency device | Enrolled subjects will undergo up to 3 successive bi-weekly (every 2 weeks) treatments, |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-07-15
- Completion
- 2022-07-20
- First posted
- 2021-01-22
- Last updated
- 2023-03-31
- Results posted
- 2023-03-31
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04719013. Inclusion in this directory is not an endorsement.